Cargando…

Persistent binding at dopamine transporters determines sustained psychostimulant effects

Psychostimulants interacting with the dopamine transporter (DAT) can be used illicitly or for the treatment of specific neuropsychiatric disorders. However, they can also produce severe and persistent adverse events. Often, their pharmacological properties in vitro do not fully correlate to their ph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niello, Marco, Sideromenos, Spyridon, Gradisch, Ralph, O´Shea, Ronan, Schwazer, Jakob, Maier, Julian, Kastner, Nina, Sandtner, Walter, Jäntsch, Kathrin, Lupica, Carl R., Hoffman, Alexander F., Lubec, Gert, Loland, Claus J., Stockner, Thomas, Pollak, Daniela D., Baumann, Michael H., Sitte, Harald H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2023
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963675/ https://www.ncbi.nlm.nih.gov/pubmed/36730201 http://dx.doi.org/10.1073/pnas.2114204120

Ejemplares similares

Allosteric Modulation of Neurotransmitter Transporters as a Therapeutic Strategy
por: Niello, Marco, et al.
Publicado: (2020)

Occlusion of the human serotonin transporter is mediated by serotonin-induced conformational changes in the bundle domain
por: Gradisch, Ralph, et al.
Publicado: (2022)

Serotonin-releasing agents with reduced off-target effects
por: Mayer, Felix P., et al.
Publicado: (2022)

The Mechanistic Basis for Noncompetitive Ibogaine Inhibition of Serotonin and Dopamine Transporters
por: Bulling, Simon, et al.
Publicado: (2012)

Handling of intracellular K(+) determines voltage dependence of plasmalemmal monoamine transporter function
por: Bhat, Shreyas, et al.
Publicado: (2021)

The conservative view: is it necessary to implant a stent into the dopamine transporter?
por: Schmid, D, et al.
Publicado: (2015)

Dual Action of Zn(2+) on the Transport Cycle of the Dopamine Transporter
por: Li, Yang, et al.
Publicado: (2015)

Adaptations of Presynaptic Dopamine Terminals Induced by Psychostimulant Self-Administration
por: Siciliano, Cody A., et al.
Publicado: (2014)

A role for cortical dopamine in the paradoxical calming effects of psychostimulants
por: Harris, Sharonda S., et al.
Publicado: (2022)

A hypothalamic dopamine locus for psychostimulant-induced hyperlocomotion in mice
por: Korchynska, Solomiia, et al.
Publicado: (2022)

The Environment Shapes the Inner Vestibule of LeuT
por: Sohail, Azmat, et al.
Publicado: (2016)

Life‐long impairment of glucose homeostasis upon prenatal exposure to psychostimulants
por: Korchynska, Solomiia, et al.
Publicado: (2019)

The role of the degenerate nucleotide binding site in type I ABC exporters
por: Stockner, Thomas, et al.
Publicado: (2020)

Deciphering structural rearrangements during transport process in the bacterial transporter GltPh, homolog to mammalian glutamate transporter
por: Venkatesan, SanthoshKannan, et al.
Publicado: (2012)

Dopamine transporter oligomerization involves the scaffold domain, but spares the bundle domain
por: Jayaraman, Kumaresan, et al.
Publicado: (2018)

The Amino Terminus of LeuT Changes Conformation in an Environment Sensitive Manner
por: Khan, Jawad A., et al.
Publicado: (2019)

Dopamine cross-sensitization between psychostimulant drugs and stress in healthy male volunteers
por: Booij, L, et al.
Publicado: (2016)

Functional Characterization of the Dopaminergic Psychostimulant Sydnocarb as an Allosteric Modulator of the Human Dopamine Transporter
por: Aggarwal, Shaili, et al.
Publicado: (2021)

A Novel and Selective Dopamine Transporter Inhibitor, (S)-MK-26, Promotes Hippocampal Synaptic Plasticity and Restores Effort-Related Motivational Dysfunctions
por: Kouhnavardi, Shima, et al.
Publicado: (2022)

Cell-Based Radiotracer Binding and Uptake Inhibition Assays: A Comparison of In Vitro Methods to Assess the Potency of Drugs That Target Monoamine Transporters
por: Ilic, Marija, et al.
Publicado: (2020)

Corrigendum: Cell-Based Radiotracer Binding and Uptake Inhibition Assays: A Comparison of In Vitro Methods to Assess the Potency of Drugs That Target Monoamine Transporters
por: Ilic, Marija, et al.
Publicado: (2022)

Structural basis of organic cation transporter-3 inhibition
por: Khanppnavar, Basavraj, et al.
Publicado: (2022)

Wake up and smell the dopamine: new mechanisms mediating dopamine activity fluctuations related to sleep and psychostimulant sensitivity
por: Kesner, Andrew J., et al.
Publicado: (2020)

Are reprogrammed cells a useful tool for studying dopamine dysfunction in psychotic disorders? A review of the current evidence
por: Sauerzopf, Ulrich, et al.
Publicado: (2016)

LRET-based intramolecular distance measurements in LeuT(Aa)
por: Sohail, Azmat, et al.
Publicado: (2011)

The effect of modafinil on the rat dopamine transporter and dopamine receptors D1–D3 paralleling cognitive enhancement in the radial arm maze
por: Karabacak, Yasemin, et al.
Publicado: (2015)

Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis
por: Keck, Thomas M., et al.
Publicado: (2015)

A Combined Approach Using Transporter-Flux Assays and Mass Spectrometry to Examine Psychostimulant Street Drugs of Unknown Content
por: Rosenauer, Rudolf, et al.
Publicado: (2012)

Occupancy of the Zinc-binding Site by Transition Metals Decreases the Substrate Affinity of the Human Dopamine Transporter by an Allosteric Mechanism
por: Li, Yang, et al.
Publicado: (2017)

PIP(2) regulates psychostimulant behaviors through its interaction with a membrane protein
por: Hamilton, Peter J., et al.
Publicado: (2014)

LRET-based distance measurements in the mammalian glutamate transporter EAAT3
por: Saha, Kusumika, et al.
Publicado: (2012)

Refinement of the Central Steps of Substrate Transport by the Aspartate Transporter GltPh: Elucidating the Role of the Na2 Sodium Binding Site
por: Venkatesan, SanthoshKannan, et al.
Publicado: (2015)

Evidence for a Role of Transporter-Mediated Currents in the Depletion of Brain Serotonin Induced by Serotonin Transporter Substrates
por: Baumann, Michael H, et al.
Publicado: (2014)

Psychostimulant Drugs and Neuroplasticity
por: Fernandez-Espejo, Emilio, et al.
Publicado: (2011)

Psychostimulants and Movement Disorders
por: Asser, Andres, et al.
Publicado: (2015)

Interactions of calmodulin kinase II with the dopamine transporter facilitate cocaine-induced enhancement of evoked dopamine release
por: Keighron, Jacqueline D., et al.
Publicado: (2023)

The metabolic regulator USF-1 is involved in the control of affective behaviour in mice
por: Sideromenos, Spyros, et al.
Publicado: (2022)

Mutational Analysis of the High-Affinity Zinc Binding Site Validates a Refined Human Dopamine Transporter Homology Model
por: Stockner, Thomas, et al.
Publicado: (2013)

The Atypical Dopamine Transporter Inhibitor CE-158 Enhances Dopamine Neurotransmission in the Prefrontal Cortex of Male Rats: A Behavioral, Electrophysiological, and Microdialysis Study
por: Sagheddu, Claudia, et al.
Publicado: (2023)

Dopamine transporter forms stable dimers in the live cell plasma membrane in a phosphatidylinositol 4,5-bisphosphate–independent manner
por: Das, Anand Kant, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_17fs0hbc8lhctj3unejsioq98h